Rise in prevalence of various chronic diseases such as cancer and cardiovascular diseases drives the growth of the global complementary and alternative medicine market.
PORTLAND, Ore., Aug. 26, 2022 /PRNewswire/ — Allied Market Research published a report, titled, “Complementary and Alternative Medicine Market by Type (Medicines, Therapy), by Disease Indication (Diabetes, Cardiovascular, Neurology, Cancer, Arthritis, Others), by Distribution Channels (Direct Sales, Online Sales, Distance Correspondence): Global Opportunity Analysis and Industry Forecast, 2021–2031.” According to the report, the global complementary and alternative medicine industry generated $102.0 billion in 2021, and is estimated to reach $437.9 billion by 2031, witnessing a CAGR of 15.6% from 2022 to 2031.
Drivers, Restraints, and Opportunities
Rise in prevalence of various chronic diseases such as cancer and cardiovascular diseases and surge in popularity of complementary and alternative medicines & therapies along with rise in costs of traditional medicines and their side effects drive the growth of the global complementary and alternative medicine market. However, side effects associated with self-medication restrain the market growth. On the other hand, rise in adoption of strategies such as collaborations, mergers, and acquisitions by leading players create new opportunities in the coming years.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/11547
Impact of Covid-19 on Complementary and Alternative Medicine Market Scenario-
Owing to the surge in COVID-19 infection worldwide and lack of availability of therapeutics for treatment against COVID-19, people turned toward complementary and alternative medicines as preventive measures and treatments.
According to the research published by Mahlagha Dehghan et. al. in January 2022, nearly 84% of the participants of the survey reported usage of one of the complementary and alternative medicines (CAMs) during the COVID-19 pandemic in Iran.
Adoption of yoga and meditation experienced a sharp rise during the pandemic due to closure of fitness centers, gyms, swimming pools, and sports stadiums with lockdown restrictions in place. So, people began therapies and exercising at home. This, in turn, led to the growth of the global complementary and alternative medicine market.
Surge in online classes and sessions that offer beginner and advanced courses related to alternative therapies such as yoga, aerobics, and meditation impacted the market positively during the pandemic.
Get detailed COVID-19 impact analysis on the Complementary and Alternative Medicine Market- https://www.alliedmarketresearch.com/request-for-customization/11547?reqfor=covid
The medicines segment to maintain its leadership status during the forecast period
Based on type, the medicines segment accounted for the highest market share in 2021, contributing to nearly two-thirds of the global complementary and alternative medicine market, and is estimated to maintain its leadership status during the forecast period. Moreover, this segment is estimated to witness the highest CAGR of 15.9% from 2022 to 2031. This is due to surge in prevalence of chronic and autoimmune disorders and increase in the adoption of natural remedies such as Ayurvedic medicines and herbal supplements. The report also analyzes the therapy segment.
The diabetes segment to maintain its dominant share during the forecast period
Based on disease indication, the diabetes segment contributed to the largest market share in 2021, accounting for nearly one-third of the global complementary and alternative medicine market, and is expected to maintain its dominant share during the forecast period. This segment is expected to manifest the largest CAGR of 16.3% from 2022 to 2031. This is attributed to rise in the prevalence of different types of diabetes and rise in geriatric population. The report also analyzes segments including cardiovascular, neurology, cancer, arthritis, and others.
The direct sales segment to continue its dominance during the forecast period
Based on distribution channel, the direct sales segment held the highest market share in 2021, accounting for nearly three-fifths of the global complementary and alternative medicine market, and is expected to continue its dominance during the forecast period. In addition, this segment is projected to manifest the highest CAGR of 16.1% during the forecast period. This is due to the adoption of natural remedies such as herbal supplements and Ayurvedic medicines along with increase in offline stores. The report also discusses segments including online sales and distance correspondence.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/11547
North America to maintain its lead status by 2031
Based on region, North America contributed to the highest market share in 2021, holding around two-fifths of the global complementary and alternative medicine market, and is expected to maintain its lead status by 2031. This is due to increase in the healthcare expenditure, the presence of major players in the country, and the strategies adopted for innovative product development. However, Asia-Pacific is projected to grow at the fastest CAGR of 16.7% from 2022 to 2031, owing to rise in prevalence of chronic diseases and abundant availability of centers for practicing yoga and meditation.
Leading Market Players
All and One Medical
AYUSH Ayurvedic Pte Ltd.
Douglas Laboratories
Herbal Hills
Herb Pharm LLC
John Schumacher Unity Woods Yoga Center
Juvenon LLC
New Life Chiropractic
Nordic Naturals
Nordic Nutraceuticals
Pure Encapsulations LLC
Quality of Life Labs
Ramamani Iyengar Memorial Yoga Institute
Sheng Chang Pharmaceutical Company
The Chicago Body Works
The Nature’s Bounty Co.
Valensa International
Official Press Release https://www.alliedmarketresearch.com/press-release/complementary-and-alternative-medicine-market.html
Similar Research Reports for Information, Communication and Technology:
Gas Chromatography Market- Global Opportunity Analysis and Industry Forecast, 2021–2030
Medical Electrodes Market- Global Opportunity Analysis and Industry Forecast, 2021–2030
3D Cell Culture Market- Global Opportunity Analysis and Industry Forecast, 2021–2030
Neurovascular Devices Market- Global Opportunity Analysis and Industry Forecast, 2021–2030
Viral Vector and Plasmid DNA Manufacturing Market- Global Opportunity Analysis and Industry Forecast, 2021–2030
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/complementary-and-alternative-medicine-market-to-reach-437-9-billion-globally-by-2031-at-15-6-cagr-allied-market-research-301612635.html
SOURCE Allied Market Research
(Reuters) -Bed Bath & Beyond Inc's chief financial officer fell to his death from New York's Tribeca skyscraper known as the "Jenga" tower on Friday afternoon, police said on Sunday, days after the struggling retailer announced it was closing stores and laying off workers. Gustavo Arnal, 52, joined Bed Bath & Beyond in 2020. Police identified the man as Gustavo Arnal.
Perhaps not: One fund manager that successfully navigated the past two major stock crashes is bracing for an awful end to the year because it fears the Federal Reserve’s quiet exit from bonds. London-based Ruffer LLP is concerned that the accelerating runoff of the Fed’s Treasury holdings will suck liquidity out of the markets—just as rising rates and falling stock and bond prices increase the need for cash to smooth the drop. “It puts a pincer on equities and bonds at the same time,” said investment director at Ruffer.
In late August, Nvidia (NASDAQ: NVDA) reported results for its fiscal second-quarter (ended July 31), and they weren't great. The long-term opportunity for Nvidia looks bright as semiconductors are rising in popularity, and the company is still seeing success in the industries with the highest potential. Second-quarter earnings results were a significant shift compared to Nvidia's previous quarters.
In this article, we discuss the 10 best value stocks to buy now. If you want to read about some more value stocks, go directly to 5 Best Value Stocks to Buy Now. It has been a wild ride for investors on Wall Street for more than a year. Stocks have experienced extreme polarization since the […]
The major indexes broke more key support last week. Apple unveils the iPhone 14 Wednesday. AAPL stock is worth watching, but this tech leader looks better.
It is Gustavo Arnal, 52, who allegedly jumped from the 18th floor of this building on September 2, says the newspaper citing police sources. "Prior to Avon, Mr. Arnal was CFO, International Divisions and Global Functions at Walgreens Boots Alliance."
(Bloomberg) — Bed Bath & Beyond Inc. Chief Financial Officer Gustavo Arnal fell to his death from a skyscraper in Manhattan’s Tribeca neighborhood on Friday. Most Read from BloombergAmazon Closes, Abandons Plans for Dozens of US WarehousesCyrus Mistry, Heir to One of India’s Oldest Fortunes, Dies at 54NASA’s Artemis Rocket Is a Gigantic Waste of MoneyGermany Takes Aim at Cost of Living Crisis in €65 Billion PlanBed Bath & Beyond Says CFO Died in Fall From NYC BuildingThe Union, New Jersey-based
The group of oil producers will keep its output steady when it meets Monday, people familiar with the matter said, as Moscow maneuvers to thwart Western attempts to limit its oil revenue following its invasion of Ukraine.
Reminiscent of communist times? Maybe it's even worse.
High oil and gas prices are boosting the energy sector as these stocks have widely outperformed the S&P 500 Index. It's no wonder: Demand for refined products remains strong and global supply is tight. It also produces renewable diesel and has a midstream segment, Valero Energy Partners LP, but its contribution to total earnings is under 10%.
The 52-year-old executive died two days after he had brief investors on the home-goods retailer’s plans to secure new financing, slash jobs and close about a fifth of its stores.
(Bloomberg) — In the aluminum industry, closing a smelter is an agonizing decision. Once power is cut and the production “pots” settle back to room temperature, it can take many months and tens of millions of dollars to bring them back online.Most Read from BloombergAmazon Closes, Abandons Plans for Dozens of US WarehousesCyrus Mistry, Heir to One of India’s Oldest Fortunes, Dies at 54NASA’s Artemis Rocket Is a Gigantic Waste of MoneyGermany Takes Aim at Cost of Living Crisis in €65 Billion Pla
These innovative businesses are giving investors reasons to buy, but a bear market just isn't cooperating.
Volkswagen plans to discuss the sports-car brand’s listing on Monday and says shares could begin trading at the end of the month.
(Bloomberg) — Investors who might be looking for the world’s biggest bond market to rally back soon from its worst losses in decades appear doomed to disappointment.Most Read from BloombergAmazon Closes, Abandons Plans for Dozens of US WarehousesCyrus Mistry, Heir to One of India’s Oldest Fortunes, Dies at 54NASA’s Artemis Rocket Is a Gigantic Waste of MoneyGermany Takes Aim at Cost of Living Crisis in €65 Billion PlanBed Bath & Beyond Says CFO Died in Fall From NYC BuildingThe US employment re
The Tesla CEO knows that oil and gas are here to stay for the long term, and so are the industry's top stocks.
The stock market’s tug of war comes as GMO’s Jeremy Grantham warns of a “superbubble.” Plus: Why social-media companies can’t make a profit.
Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Workday Inc. recently was downgraded to Sell with a D+ rating by TheStreet's Quant Ratings.
First Eagle Investments is an independent, privately owned asset management firm dedicated to serving the needs of individuals and institutions worldwide as well as the financial professionals that advise them. Recently, the fund published its “First Eagle Investments Global Fund” second-quarter 2022 investor letter – a copy of which can be downloaded here. The fund […]
These fast-paced companies have the sustainable competitive advantages necessary to make patient investors a lot richer over the next decade.
